175 related articles for article (PubMed ID: 35371270)
1. Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia.
Cheong WK; Chan AWM; Ch'ng CC; Chung WH; Gabriel MT; Godse K; Mitthamsiri W; Nguyen HT; Tiongco-Recto M; Nagrale D
Drugs Context; 2022; 11():. PubMed ID: 35371270
[TBL] [Abstract][Full Text] [Related]
2. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
Yagami A; Furue M; Togawa M; Saito A; Hide M
J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
[TBL] [Abstract][Full Text] [Related]
3. Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement.
Mösges R; Lee DL; Abong J; Siasoco B; Chow SK; Leong JL; Singh H; Kuljit S; Campomanes B
Asia Pac Allergy; 2016 Jan; 6(1):56-66. PubMed ID: 26844221
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria.
Rodríguez M; Vozmediano V; García-Bea A; Novák Z; Yáñez A; Campo C; Labeaga L
Eur J Pediatr; 2020 May; 179(5):801-805. PubMed ID: 31919579
[TBL] [Abstract][Full Text] [Related]
5. How bilastine is used to treat allergic rhinitis and urticaria in children.
Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
[TBL] [Abstract][Full Text] [Related]
6. Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.
Wang XY; Lim-Jurado M; Prepageran N; Tantilipikorn P; Wang de Y
Ther Clin Risk Manag; 2016; 12():585-97. PubMed ID: 27110120
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
8. An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options.
Church MK; Canonica GW; Kuna P; Maurer M; Mösges R; Novak Z; Papadopoulos NG; Rodriguez Del Rio P;
Expert Rev Clin Immunol; 2023; 19(7):813-820. PubMed ID: 37191185
[TBL] [Abstract][Full Text] [Related]
9. Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.
Wolthers OD
Biomed Res Int; 2013; 2013():626837. PubMed ID: 23956994
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine.
Lynde CW; Sussman G; Dion PL; Guenther L; Hébert J; Rao J; Leek TV; Waserman S
J Drugs Dermatol; 2020 Feb; 19(2):145-154. PubMed ID: 32129958
[TBL] [Abstract][Full Text] [Related]
11. Bilastine: a lifetime companion for the treatment of allergies.
Church MK; Tiongco-Recto M; Ridolo E; Novák Z
Curr Med Res Opin; 2020 Mar; 36(3):445-454. PubMed ID: 31612732
[No Abstract] [Full Text] [Related]
12. The safety and tolerability profile of bilastine for chronic urticaria in children.
Papadopoulos NG; Zuberbier T
Clin Transl Allergy; 2019; 9():55. PubMed ID: 31660121
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
Hide M; Yagami A; Togawa M; Saito A; Furue M
Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Safety of Bilastine 10 mg/d in Children Aged 2 to 5 Years With Allergic Rhinoconjunctivitis or Urticaria: A Phase 3 Clinical Trial.
Majorek-Olechowska B; Slomskis T; Zollerová L; Martín I; Sánchez C; Gilaberte I; Arranz P;
J Investig Allergol Clin Immunol; 2024 May; ():0. PubMed ID: 38725318
[TBL] [Abstract][Full Text] [Related]
15. Bilastine: new insight into antihistamine treatment.
Ridolo E; Montagni M; Bonzano L; Incorvaia C; Canonica GW
Clin Mol Allergy; 2015; 13(1):1. PubMed ID: 25878559
[TBL] [Abstract][Full Text] [Related]
16. Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study.
Canonica GW; Kuna P; Maurer M; Mösges R; Novak Z; Papadopoulos N; Rodriguez Del Rio P;
Drugs Context; 2024; 13():. PubMed ID: 38742145
[TBL] [Abstract][Full Text] [Related]
17. Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients.
De A; Godse K; Dhoot D; Sarda A
Indian J Dermatol; 2021; 66(2):159-164. PubMed ID: 34188271
[TBL] [Abstract][Full Text] [Related]
18. Bilastine: in allergic rhinitis and urticaria.
Carter NJ
Drugs; 2012 Jun; 72(9):1257-69. PubMed ID: 22686617
[TBL] [Abstract][Full Text] [Related]
19. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
[TBL] [Abstract][Full Text] [Related]
20. Bilastine for the treatment of urticaria.
Jáuregui I; Ferrer M; Bartra J; del Cuvillo A; Dávila I; Montoro J; Mullol J; Sastre J; Valero A
Expert Opin Pharmacother; 2013 Aug; 14(11):1537-44. PubMed ID: 23675825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
